Drug Trial Radar · NCT03796676
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Apr 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
287
Actual
Start
Feb 18, 2019
Primary completion
Apr 8, 2020
Study completion Apr 8, 2020
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jan 8, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to \<18 years of age with moderate to severe AD.
Conditions
- Atopic Dermatitis
Interventions
PlaceboDrug
Placebo
PF-04965842Drug
100 mg QD
PF04965842Drug
200 mg QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Investigator's Global Assessment (IGA) Response of 'Clear' (0) or 'Almost Clear' (1) and ≥2 Points Improvement From Baseline at Week 12Time frame: Baseline to Week 12
- Percentage of Participants Achieving Eczema Area and Severity Index (EASI) Response ≥ 75% Improvement From Baseline at Week 12Time frame: Baseline to Week 12
Locations
136 sites in 14 countries. Site status is shown where the registry gives one.
Clinical Research Center of Alabama, LLC
Birmingham, Alabama
Madera Family Medical Group
Madera, California
Allergy & Asthma Associates of Southern California dba Southern California Research
Mission Viejo, California
UC Davis
Sacramento, California
Moonshine Research Center, Inc.
Doral, Florida
Homestead Research Institute
Homestead, Florida
Olympian Clinical Research
Largo, Florida
Clinical Trials Solutions
Miami, Florida
Global Health Clinical Trials Corp
Miami, Florida
La Salud Research Clinic, Inc.
Miami, Florida
Nicklaus Children's Hospital
Miami, Florida
South Miami Medical & Research Group, Inc.
Miami, Florida
Ciocca Dermatology, PA
Miami, Florida
INTERMED Medical Research Center, Inc
Miami, Florida
Suncoast Research Associates
Miami, Florida
AdventHealth Orlando
Orlando, Florida
AdventHealth Pediatric Dermatology Orlando
Orlando, Florida
AdventHealth Orlando - Investigational Drug Services
Orlando, Florida
Outpatient Service Center-AdventHealth Orlando
Orlando, Florida
Pediatric Outpatient Procedures and Sedation
Orlando, Florida
NeuroSkeletal Imaging
Orlando, Florida
Accel Research Sites - Pure Skin Dermatology & Aesthetics
Orlando, Florida
Accel Research Sites - Nona Pediatric Center
Orlando, Florida
ForCare Clinical Research
Tampa, Florida
Columbus Regional Research Institute
Columbus, Georgia
Meridian Clinical Research, LLC
Savannah, Georgia
Midwest Allergy Sinus Asthma, SC
Normal, Illinois
NorthShore University HealthSystem Dermatology Clinical Trials Unit
Skokie, Illinois
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
The South Bend Clinic Center for Research
South Bend, Indiana
Forefront Dermatology S.C.
Louisville, Kentucky
Institute for Asthma and Allergy
Chevy Chase, Maryland
DermAssociates, LLC
Rockville, Maryland
Chesapeake Clinical Research, Inc.
White Marsh, Maryland
Clarkston Skin Research
Clarkston, Michigan
Wayne State University / Integrative Biosciences Center
Detroit, Michigan
Center for Outpatient Health
St Louis, Missouri
St. Louis Children's Hospital
St Louis, Missouri
St. Louis Children's Hospital
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
Showing 40 of 136 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.